New concepts in antimalarial use and mode of action in dermatology.
about
Interventions for cutaneous disease in systemic lupus erythematosusCurrent and emerging pharmacological treatments for sarcoidosis: a reviewMolecular targets in arthritis and recent trends in nanotherapyInhibition of RNA Recruitment and Replication of an RNA Virus by Acridine Derivatives with Known Anti-Prion ActivitiesAcute pretreatment with chloroquine attenuates renal I/R injury in ratsBeyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancersGranulomatous disease in common variable immunodeficiency.Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.Autoimmunity in common variable immunodeficiency.CD4+ CD25+ Foxp3+ regulatory T cells, dendritic cells, and circulating cytokines in uncomplicated malaria: do different parasite species elicit similar host responses?Reduction of immune activation with chloroquine therapy during chronic HIV infectionMechanisms of premature atherosclerosis in rheumatoid arthritis and lupusTherapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malariaThe interplay of inflammation and cardiovascular disease in systemic lupus erythematosus.Acquired facial lipoatrophy: pathogenesis and therapeutic options.Treatment of cutaneous lupus.Response to antimalarial agents in cutaneous lupus erythematosus: a prospective analysis.Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment.Suppression of TLR signaling by targeting TIR domain-containing proteinsPharmacokinetics and Bioequivalence Study of Hydroxychloroquine Sulfate Tablets in Chinese Healthy Volunteers by LC-MS/MS.The place of William Osler in the description of systemic lupus erythematosusTherapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer.Can rheumatoid arthritis be prevented?Frontal Fibrosing Alopecia Coexisting with Lupus Erythematosus: Poor Response to Hydroxychloroquine.Current knowledge and challenges of antimalarial drugs for treatment and prevention in pregnancy.Cutaneous lupus erythematosus: recent lessons from animal models.Hydroxychloroquine: from malaria to autoimmunity.Toll-like receptors in rheumatic diseases: are we paying a high price for our defense against bugs?The role of antimalarial agents in the treatment of SLE and lupus nephritis.Chronic non-granulomatous supraglottitis: a rare and difficult disease.Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects.The clinical significance of drug interactions between dermatological and psychoactive medications.Targeting CD4(+) T cells for the treatment of sarcoidosis: a promising strategy?Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases.Screening and vaccinations in patients requiring systemic immunosuppression: an update for dermatologists.The enigma of the clandestine association between chloroquine and HIV-1 infection.Autophagy: controlling cell fate in rheumatic diseases.The lysosomal inhibitor, chloroquine, increases cell surface BMPR-II levels and restores BMP9 signalling in endothelial cells harbouring BMPR-II mutationsSynthesis and biological evaluation of acridine derivatives as antimalarial agents.Nutritional stress and arginine auxotrophy confer high sensitivity to chloroquine toxicity in mesothelioma cells.
P2860
Q24242236-AAABF37D-52F0-40CD-B5F7-74C2A0D66B75Q24633717-959B36DB-7026-4CBF-AE0A-09FD69058968Q26783466-B12C15F3-BC75-42E3-84C1-ED65EDAFAB22Q27489873-90D44294-544E-413A-8D0B-71DFFCEAC426Q28541693-0C264186-D5EF-4749-8B48-8F8CA3F1D456Q28743513-D79B9866-5A16-44BC-9BC1-D915FE647817Q33386034-84207A97-333D-4FE3-88E3-211A3E71CC4DQ33587443-A0BF666E-0C6D-4039-8BDD-7D91D7E64E7DQ34056308-63E42EC2-2D3C-4AD4-BD20-C02988D21C1AQ34290893-670C13D0-F021-463F-9E14-B104AD08AE43Q34296062-5A7AEC97-28C2-4809-92AE-A766DEB11101Q34343906-A9448232-461A-4B04-9D91-BF5DDC2FFFECQ34621573-DA0775AE-5D5E-4B17-B0D6-44B7401FE572Q35169351-4686CCD8-B4B1-4ABC-AAD5-A95E14A5A598Q35620537-EB0D9264-8354-4561-A841-CB0D30CC8491Q35633324-1C927B79-D592-4312-9DDA-EBF4BE0CAED4Q35764302-B10F5197-3924-453A-91D5-ECA67EC2AE1BQ35803068-8402BC48-3136-4631-80A2-DABA165A5E41Q36676056-77A73511-ECF5-4229-AAD3-93794186FF7FQ36942997-FC5ACE35-B028-4F44-9E77-7E0155DDD888Q37438428-7F16D219-AE6A-4357-8379-F783A107BEE6Q37497786-F5D5EF71-AFA4-4396-B374-4675C768176DQ37589108-3EBB2EFE-DE32-49D8-83C6-58F7B9DDB9E2Q37604787-91E42A8E-306B-49B7-83B0-2091B31AC2E1Q37735182-DA759F3E-8A3B-4426-8FAE-239C5ABCD7CDQ37778643-F9C8E11A-DEED-4C1D-8C64-4A6103501EEDQ37827403-746152C7-7ABD-4E8B-BFEB-4B8453D40598Q37868069-52DB3038-EC95-47A9-AEC1-467D664436D7Q37947108-AECB04A0-2155-490D-88CF-858EC530E6CDQ38014130-C3001691-8DCA-43A7-9F8F-D4941F174D86Q38029146-0E38BAFE-F20C-489C-8978-87C0330FC5BAQ38185684-1907A75B-F9D6-4DD3-9E46-D83100CC5ED3Q38311906-9AF138A5-10B9-4510-B5C3-719B944A8BCFQ38360827-850E45FF-C2EC-49C9-BF50-548CCC755BC1Q38411930-69C201FC-50A3-4094-9D67-56107FA03A4CQ38559764-1DE59205-576D-4218-A4C0-00A2BF35A18AQ38873681-7C7A2D97-9C0E-4032-BD04-972C861B2135Q39152712-DB2F5505-D568-4371-A645-BC06330B71D9Q39396932-DF476DA8-731C-48FF-B29C-410CA2C69A0DQ39444979-8F41FF63-1D50-40AC-9096-C33AFA13A865
P2860
New concepts in antimalarial use and mode of action in dermatology.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
New concepts in antimalarial use and mode of action in dermatology.
@ast
New concepts in antimalarial use and mode of action in dermatology.
@en
New concepts in antimalarial use and mode of action in dermatology.
@nl
type
label
New concepts in antimalarial use and mode of action in dermatology.
@ast
New concepts in antimalarial use and mode of action in dermatology.
@en
New concepts in antimalarial use and mode of action in dermatology.
@nl
prefLabel
New concepts in antimalarial use and mode of action in dermatology.
@ast
New concepts in antimalarial use and mode of action in dermatology.
@en
New concepts in antimalarial use and mode of action in dermatology.
@nl
P2860
P1433
P1476
New concepts in antimalarial use and mode of action in dermatology.
@en
P2093
Jan P Dutz
Sunil Kalia
P2860
P304
P356
10.1111/J.1529-8019.2007.00131.X
P577
2007-07-01T00:00:00Z